-
Study: Fluvoxamine lowers risk of hospitalisation from COVID-19
28 October, 2021
A large randomised clinical trial has found that...COVID-19
-
WHO COVID-19 Weekly Reports, October 2021
27 October, 2021
Weekly reports on the global COVID-19 situation from the WHO...COVID-19
-
Study finds vaccine safe even with allergies
United States // 27 October, 2021
Most completed the series even with symptoms…COVID-19
-
Molnupiravir licensed for free in low-income countries
United States // 27 October, 2021
More than 100 countries to see expanded access…COVID-19
-
Vaccinations of children (3-11 years) begins
China // 27 October, 2021
Covid vaccination of 3-11 years begins in some Chinese provincesCOVID-19
-
EMA recommends Spikevax booster for 18 years and older
27 October, 2021
EMA recommends Moderna's vaccine for 18 years and olderCOVID-19
-
ECDC advice on using COVID-19 rapid antigen tests
27 October, 2021
Although many of the rapid antigen tests are not as sensitive as standard tests, they can be used in ways that recognise this issue....COVID-19
-
WHO emergency committee meetings on the COVID-19 pandemic
26 October, 2021
The pandemic remains a PHEIC...COVID-19
-
EMA begins speedy review of new antiviral medication
25 October, 2021
Preliminary evidence is promising…COVID-19
-
Vaccine update - adults aged 18 and over are now eligible
Botswana // 25 October, 2021
Botswana has expanded its vaccination campaign...COVID-19
-
Hubei Province to vaccinate children
China // 25 October, 2021
Children aged 3-11 years will be eligible…COVID-19
-
Study: COVID-19 likely to be a seasonal infection
22 October, 2021
Evidence suggests that COVID-19 could be a seasonal infection...COVID-19
-
US regulatory agencies recommend booster vaccination
United States // 21 October, 2021
Booster dose eligibility expanded…COVID-19
-
Study: Mild COVID-19 lasts longer in obese and overweight individuals
21 October, 2021
Overweight and obese individuals with mild COVID-19 have higher chances of longer duration of symptoms...COVID-19
-
Pfizer-BioNTech COVID-19 vaccine approved for 12 to 15 year olds, study results published
United States // 20 October, 2021
Study results from trials of the Pfizer-BioNTech vaccine in 12 to 15 years show favourable results...COVID-19
-
International travel pass launched
Australia // 19 October, 2021
The pass is now available for use...COVID-19
-
COVID-19 Update – Cases rising in fifth wave
Finland // 18 October, 2021
Finland is experiencing the fifth wave...COVID-19
-
ECDC report on improving acceptance of COVID-19 vaccine across EU/EEA countries
15 October, 2021
Based on a "5Cs" model...COVID-19
-
WHO Assessment - Only one in seven COVID-19 cases detected in Africa
14 October, 2021
WHO AFRO announced a new initiative to improve COVID-19 detection in Africa...COVID-19
-
The role of face coverings in transmission of COVID-19, Public Health England
14 October, 2021
Statement from Public Health England's Respiratory Evidence Panel...COVID-19